Dose escalated BEACOPP chemotherapy improves failure free survival in advanced Hodgkin's disease: Updated results of the German Hodgkin's Lymphoma Study Group.

2000 | conference abstract. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Dose escalated BEACOPP chemotherapy improves failure free survival in advanced Hodgkin's disease: Updated results of the German Hodgkin's Lymphoma Study Group.​
Diehl, V.; Franklin, J.; Sieber, M.; Hasenclever, D.; Wolf, J.; Engert, A. & Hermann, R. et al.​ (2000)
Blood, 96(11) pp. 576A​-+. 
Washington​: Amer Soc Hematology.

Copy

Further links

Documents & Media

License

GRO License GRO License

Details

Authors
Diehl, Volker; Franklin, J.; Sieber, M.; Hasenclever, Dirk; Wolf, J.; Engert, Andreas; Hermann, R.; Longin, C.; Koch, P.; Wulf, Gerald; Hanel, M.; Muller-Hermelink, H. K.; Duhmke, E.; Loeffler, Markus
Issue Date
2000
Status
published
Publisher
Amer Soc Hematology
Journal
Blood 
ISSN
0006-4971

Export Metadata

Refman EndNote BibTeX RefWorks Excel CSV

Reference

Citations